AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

DABUR PHARMA RECEIVES INDIAN REGULATOR'S NOD FOR NANOXEL.

AsiaPulse News

| February 01, 2008 | COPYRIGHT 2008 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

MUMBAI, Feb 1 Asia Pulse - Dabur Pharma Ltd (BSE:532545) on Thursday said it has got approval from the Drug Controller General of India (DCGI) for its anti-cancer drug delivery formulation 'Nanoxel' (nanoparticle paclitaxel) as an indication for three more types of cancer.

The company informed the stock exchanges that its proprietary Nanoxel has been approved by DGCI for treatment of ovarian Cancer, non-small cell lung cancer and also for AIDS related Kaposis' Sarcoma (abnormal growth of tissues under the skin).

"This approval will help a ...

Related articles from newspapers, magazines, journals, and more
Open offer for Dabur Pharma shareholders rescheduled to June20.
News wire article from: PTI - The Press Trust of India Ltd. June 17, 2008 700+ words
Open offer for Dabur Pharma shareholders rescheduled to June20 Mumbai, June 17 (PTI) -- Dabur Pharma today said the open offer to its shareholders...20 per cent in Burman family-owned Dabur Pharma at Rs 76.50 per share. Morgan Stanley...
OPEN OFFER FOR DABUR PHARMA SHAREHOLDERS RESCHEDULED TO JUNE 20.
News wire article from: AsiaPulse News June 18, 2008 700+ words
MUMBAI, June 18 Asia Pulse - Dabur Pharma (BSE:532545) on Tuesday said an...20 per cent in Burman family-owned Dabur Pharma at Rs 76.50 per share. Morgan Stanley...persons acting in concert/PACs), Dabur Pharma said in a filing to the Bombay Stock...
Dabur Pharma sets arm in US to tap oncology market.
News wire article from: PTI - The Press Trust of India Ltd. May 9, 2007 700+ words
Dabur Pharma sets arm in US to tap oncology market Mumbai, May 9 (PTI) Dabur Pharma today said it has set up a subsidiary company...products in that country. The incorporation of Dabur Pharma's US subsidiary comes close on the heels...
Dabur Pharma eyes China & Japan entry.
Newspaper article from: Economic Times (New Delhi, India) August 2, 2007 700+ words
...Domestic anti-cancer drug major Dabur Pharma is finalising plans to enter Japan and...acquisitions in both the countries. Dabur Pharma feels an acquisition in either China...undertaken from India. This was confirmed by Dabur Pharma CEO Ajay K Vij. Talking to ET, Mr...
Dabur Pharma to change its name to Fresenius Kabi Oncology.
News wire article from: PTI - The Press Trust of India Ltd. October 24, 2008 700+ words
Dabur Pharma to change its name to Fresenius Kabi Oncology Mumbai, Oct 24 (PTI) Dabur Pharma today said the company would rechristen...company and its wholly-owned subsidiaries, Dabur Pharma, said in a filing to the BSE. Fresenius...
Dabur Pharma forays into Pakistan anti-cancer drug market.
News wire article from: PTI - The Press Trust of India Ltd. August 5, 2007 700+ words
Dabur Pharma forays into Pakistan anti-cancer drug...Stepping up its overseas expansion, Dabur Pharma has made a foray into the anti-cancer...anti-cancer drugs to Pakistan," Dabur Pharma Additional Director and Non-Executive...
Dabur Pharma gets Government nod for name change.
News wire article from: PTI - The Press Trust of India Ltd. January 13, 2009 700+ words
Dabur Pharma gets Government nod for name change Mumbai, Jan 13 (PTI) Dabur Pharma today said it has received the government...In a filing to the Bombay Stock Exchange, Dabur Pharma informed that central government has accorded...
Dabur Pharma gets proposal from Fresenius for jointly dev biz.
News wire article from: PTI - The Press Trust of India Ltd. August 11, 2008 700+ words
Dabur Pharma gets proposal from Fresenius for jointly...11 (PTI) Cancer drug manufacturer Dabur Pharma Ltd today said it has approved the letter...the Indian firm and its subsidiaries, Dabur Pharma said in a filling to Bombay Stock Exchange...
For more facts and information, see all results

Source: HighBeam Research, DABUR PHARMA RECEIVES INDIAN REGULATOR'S NOD FOR NANOXEL.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA